Medical Balloon Manufacturing Market Report 2026
Global Outlook – By Balloon Type (Angioplasty Balloons, Stent Delivery Balloons, Drug-Coated Balloons, Occlusion Balloons, Dilatation Balloons, Extraction Balloons, Specialty Balloons, Other Balloon Types), By Material (Polyamide, Polyethylene Terephthalate, Polyurethane, Polyether Block Amide, Silicone), By Manufacturing Process (Polymer Extrusion, Stretch Blow Molding, Balloon Forming Or Thermoforming, Laser Welding And Assembly, Catheter Bonding And Assembly), By Application (Coronary Interventions, Peripheral Vascular Interventions, Neurovascular Procedures, Urology, Gastroenterology, Pulmonology, Other Applications), By End User (Medical Device Manufacturers, Contract Manufacturing Organizations, Research And Development Organizations) – Market Size, Trends, Strategies, and Forecast to 2030
Medical Balloon Manufacturing Market Overview
• Medical Balloon Manufacturing market size has reached to $0.91 billion in 2025 • Expected to grow to $1.21 billion in 2030 at a compound annual growth rate (CAGR) of 5.7% • Growth Driver: Increasing Prevalence Of Cardiovascular Diseases Is Fueling The Market Due To Rising Rates Of Hypertension • Market Trend: Development Of Advanced Balloon Technologies For Complex Vascular Interventions • North America was the largest region in 2025 and Asia-Pacific is the fastest growing region.What Is Covered Under Medical Balloon Manufacturing Market?
Medical balloon manufacturing refers to the specialized production of ultra-thin, expandable balloons designed for use with catheter-based medical devices. The manufacturing process involves precision polymer processing, forming, and assembly techniques to achieve controlled balloon dimensions, wall thickness, flexibility, and pressure resistance. These balloons are engineered to provide reliable expansion and conformability during minimally invasive procedures, while meeting stringent performance, quality, and safety requirements. The main balloon types of medical balloon manufacturing include angioplasty balloons, stent delivery balloons, drug-coated balloons, occlusion balloons, dilatation balloons, extraction balloons, specialty balloons, and other balloon types. Angioplasty balloons refer to inflatable medical devices used to dilate narrowed or blocked blood vessels during minimally invasive procedures. These balloons are manufactured using polyamide, polyethylene terephthalate, polyurethane, polyether block amide, and silicone through polymer extrusion, stretch blow molding, balloon forming or thermoforming, laser welding and assembly, and catheter bonding and assembly. The various applications involved are coronary interventions, peripheral vascular interventions, neurovascular procedures, urology, gastroenterology, pulmonology, and others, and they are used by several end users such as medical device manufacturers, contract manufacturing organizations, and research and development organizations.
What Is The Medical Balloon Manufacturing Market Size and Share 2026?
The medical balloon manufacturing market size has grown strongly in recent years. It will grow from $0.91 billion in 2025 to $0.97 billion in 2026 at a compound annual growth rate (CAGR) of 6.0%. The growth in the historic period can be attributed to rising adoption of minimally invasive procedures, increasing demand for catheter-based medical devices, growing use of angioplasty and dilatation balloons, increasing need for precision medical device components, rising demand for reliable balloon performance.What Is The Medical Balloon Manufacturing Market Growth Forecast?
The medical balloon manufacturing market size is expected to see strong growth in the next few years. It will grow to $1.21 billion in 2030 at a compound annual growth rate (CAGR) of 5.7%. The growth in the forecast period can be attributed to growing demand for next-generation specialty medical balloons, increasing adoption of advanced polymer materials, rising demand for ultra-thin balloon walls, growing use of automated balloon manufacturing processes, increasing demand for high-pressure and high-compliance balloon designs. Major trends in the forecast period include increasing adoption of ultra-thin medical balloon designs, growing demand for high-pressure balloon manufacturing, rising use of advanced polymer forming techniques, increasing demand for precise balloon dimensional control, growing adoption of high-flexibility and conformable balloon structures.
Global Medical Balloon Manufacturing Market Segmentation
1) By Balloon Type: Angioplasty Balloons, Stent Delivery Balloons, Drug-Coated Balloons, Occlusion Balloons, Dilatation Balloons, Extraction Balloons, Specialty Balloons, Other Balloon Types 2) By Material: Polyamide, Polyethylene Terephthalate, Polyurethane, Polyether Block Amide, Silicone 3) By Manufacturing Process: Polymer Extrusion, Stretch Blow Molding, Balloon Forming Or Thermoforming, Laser Welding And Assembly, Catheter Bonding And Assembly 4) By Application: Coronary Interventions, Peripheral Vascular Interventions, Neurovascular Procedures, Urology, Gastroenterology, Pulmonology, Other Applications 5) By End User: Medical Device Manufacturers, Contract Manufacturing Organizations, Research And Development Organizations Subsegments: 1) By Angioplasty Balloons: Peripheral Angioplasty Balloons, Coronary Angioplasty Balloons, Neurovascular Angioplasty Balloons 2) By Stent Delivery Balloons: Coronary Stent Delivery Balloons, Peripheral Stent Delivery Balloons, Neurovascular Stent Delivery Balloons 3) By Drug-Coated Balloons: Paclitaxel-Coated Balloons, Sirolimus-Coated Balloons, Other Drug-Coated Balloons 4) By Occlusion Balloons: Temporary Occlusion Balloons, Permanent Occlusion Balloons, Flow-Control Occlusion Balloons 5) By Dilatation Balloons: High-Pressure Dilatation Balloons, Low-Pressure Dilatation Balloons, Cutting Or Scoring Dilatation Balloons 6) By Extraction Balloons: Foreign Body Extraction Balloons, Stone Extraction Balloons, Thrombus Extraction Balloons 7) By Specialty Balloons: Cutting Balloons, Scoring Balloons, Cryogenic Balloons 8) By Other Balloon Types: Valvuloplasty Balloons, Ablation Balloons, Mapping Balloons, Embolization BalloonsWhat Is The Driver Of The Medical Balloon Manufacturing Market?
The increasing prevalence of cardiovascular diseases is expected to propel the growth of the medical balloon manufacturing market going forward. Cardiovascular diseases (CVDs) refer to a group of disorders affecting the heart and blood vessels. They include conditions such as coronary artery disease, heart attack, stroke, heart failure, arrhythmias, and peripheral artery disease. The prevalence of cardiovascular diseases is rising due to increasing rates of hypertension, obesity, physical inactivity, and unhealthy dietary patterns, which contribute to arterial damage and atherosclerosis. Medical balloon manufacturing supports cardiovascular disease management by enabling minimally invasive procedures such as angioplasty and stent placement. These balloons help restore blood flow by widening narrowed or blocked blood vessels, reducing the need for open surgery and improving patient recovery. For instance, in February 2026, according to the American Heart Association, a US-based nonprofit organization focused on cardiovascular health, 6 in 10 U.S. adults are projected to have cardiovascular disease by 2050, driven by population aging and increasing cardiovascular risk factors. Additional projections indicate that heart valve disease could double by 2040 and triple by 2060, further increasing the need for cardiovascular interventions and catheter-based treatment technologies. Therefore, the increasing prevalence of cardiovascular diseases is driving the growth of the medical balloon manufacturing industry.Key Players In The Global Medical Balloon Manufacturing Market
Major companies operating in the medical balloon manufacturing market are Abbott Laboratories, Medtronic plc, Boston Scientific Corporation, Becton Dickinson and Company, Terumo Corporation, Integer Holdings Corporation, B. Braun SE, Cook Group Incorporated, Cordis Corporation, BIOTRONIK SE & Co. KG, Kaneka Corporation, Merit Medical Systems Inc, Lepu Medical Technology (Beijing) Co. Ltd, OrbusNeich Medical Company Ltd, Biomerics LLC, Endologix LLC, BrosMed Medical Co. Ltd, Tokai Medical Products Inc, Hexacath SA, NATEC Medical Ltd, iVascular S.L.U., Balton Sp. z o.o., Concept Medical Inc
This chart is for illustrative purposes; the full report includes a detailed competitor analysis and comprehensive overview of the top 10 companies in the market.
This chart maps companies by product innovation and brand strength, with bubble size indicating relative revenue, helping identify market leaders, challengers, and niche players. This is an illustrative chart; the full report provides a complete and accurate competitive analysis.
Explore how leading companies compare across key metrics in our report Get Report
Global Medical Balloon Manufacturing Market Trends and Insights
Major companies operating in the medical balloon manufacturing market are focusimg on developing advanced products, such as next-generation intravascular lithotripsy (IVL) catheters, to address unmet clinical needs in deliverability, lesion crossing, and balloon repositioning for treating calcified coronary artery disease. Next-generation IVL catheters refer to advanced mechanisms in balloon-based systems that use ultrasonic acoustic pressure waves to crack hardened calcium, while featuring enhanced shaft flexibility, tapered tips with hydrophilic coatings, and improved balloon deflation for easier navigation and repositioning within tortuous arteries. For instance, in May 2026, Johnson & Johnson, a US-based medical technology company, launched the Shockwave C2 Aero Coronary IVL Catheter, a next-generation balloon-based intravascular lithotripsy catheter designed to improve deliverability through tortuous coronary anatomy, facilitate crossing of heavily calcified lesions, and enable balloon repositioning. The device incorporates a more flexible balloon material, tapered tip, hydrophilic coating, and compact balloon deflation and rewrapping capabilities. These advancements require precise balloon forming, specialized material processing, catheter assembly, and stringent quality-control technologies, thereby supporting innovation in medical balloon manufacturing.What Are Latest Mergers And Acquisitions In The Medical Balloon Manufacturing Market?
In September 2024, Quasar Medical, a US-based manufacturer of complex minimally invasive medical devices, acquired Ridgeback Technologies Ltd. for an undisclosed amount. The acquisition expanded Quasar Medical's in-house capabilities in balloon design, prototyping, mold manufacturing, extrusion, injection molding, and catheter assembly, strengthening its end-to-end medical balloon manufacturing capabilities and enabling faster scale-up and customized balloon catheter production. Ridgeback Technologies Ltd. is a US-based medical device company specializing in the design, development, and manufacture of catheter balloons and complete balloon catheter assemblies.
Regional Insights
North America was the largest region in the medical balloon manufacturing market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in this market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.Need data for a specific geography? Request Regional Data
What Defines the Medical Balloon Manufacturing Market?
The medical balloon manufacturing consists of sales of cutting balloons, scoring balloons, lithotripsy balloons, perfusion balloons and embolectomy balloons. Values in this market are ‘factory gate’ values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream medical device manufacturers, catheter assemblers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.How is Market Value Defined and Measured?
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
This chart presents market attractiveness based on a quantitative evaluation of growth, competition, strategic alignment, and risk, offering a clear view of opportunity areas for decision-making. This chart is for illustrative purposes; the full report contains the complete analysis.
This chart highlights the Total Addressable Market (TAM) by estimating the maximum revenue opportunity using an assumption-driven approach, supporting strategic planning and opportunity sizing across markets. The chart is illustrative; the full report provides a more comprehensive analysis.
Access full TAM calculations and growth projections in our report Get Report
What Key Data and Analysis Are Included in the Medical Balloon Manufacturing Market Report 2026?
The medical balloon manufacturing market research report is one of a series of new reports from The Business Research Company that provides market statistics, including industry global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the medical balloon manufacturing industry. The market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.Medical Balloon Manufacturing Market Report Forecast Analysis
| Report Attribute | Details |
|---|---|
| Market Size Value In 2026 | $0.97 billion |
| Revenue Forecast In 2030 | $1.21 billion |
| Growth Rate | CAGR of 5.7% from 2026 to 2030 |
| Base Year For Estimation | 2025 |
| Actual Estimates/Historical Data | 2020-2025 |
| Forecast Period | 2026 - 2030 |
| Market Representation | Revenue in USD Billion and CAGR from 2026 to 2030 |
| Segments Covered | Balloon Type, Material, Manufacturing Process, Application, End User |
| Regional Scope | Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa |
| Country Scope | The countries covered in the report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain. |
| Key Companies Profiled | Abbott Laboratories, Medtronic plc, Boston Scientific Corporation, Becton Dickinson and Company, Terumo Corporation, Integer Holdings Corporation, B. Braun SE, Cook Group Incorporated, Cordis Corporation, BIOTRONIK SE & Co. KG, Kaneka Corporation, Merit Medical Systems Inc, Lepu Medical Technology (Beijing) Co. Ltd, OrbusNeich Medical Company Ltd, Biomerics LLC, Endologix LLC, BrosMed Medical Co. Ltd, Tokai Medical Products Inc, Hexacath SA, NATEC Medical Ltd, iVascular S.L.U., Balton Sp. z o.o., Concept Medical Inc |
| Customization Scope | Request for Customization |
| Pricing And Purchase Options | Explore Purchase Options |